Cochlear receives FDA approval for Nucleus Profile Plus Series

The Cochlear Limited(ASX: COH) share price will be on watch this morning after the manufacturer and distributor of cochlear implantable devices released an update on its Nucleus Profile Plus Series. What was in the update? According to the release, Cochlear…
Read More